Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1999
12/29/1999WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999WO1999066948A2 Use of a dipeptide for stimulating repair processes
12/29/1999WO1999066942A1 Compounds obtained from salvia species having antiviral activity
12/29/1999WO1999066941A1 Herbal extract composition and method with immune-boosting capability
12/29/1999WO1999066936A1 Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
12/29/1999WO1999066931A1 Use of 1-(aminoalkyl)-3-quinoxaline-2-one derivatives for the preparation of compounds having an antioxidant action
12/29/1999WO1999066928A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999WO1999066927A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999WO1999066917A2 Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid
12/29/1999WO1999066906A1 Sticking plaster for controlled release of natural interferon
12/29/1999WO1999066875A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999WO1999058639A3 Structural proteins of fish pancreatic disease virus and uses thereof
12/29/1999WO1999057284A3 Attenuated influenza viruses
12/29/1999WO1999057125A3 Hygromycin a derivatives
12/29/1999WO1999055830A3 Process for synthesizing cox-2 inhibitors
12/29/1999WO1999055715A3 Polysaccharide-antigen conjugates
12/29/1999WO1999055377A3 Polyol-ifn-beta conjugates
12/29/1999WO1999054326A8 Dihydropyrimidines
12/29/1999WO1999042564A3 Apoptotic cell-mediated antigen presentation to dendritic cells
12/29/1999WO1998055150A8 Txu-7-pap immunotoxin and use thereof
12/29/1999EP0967279A1 Helicobacter pylori cytotoxin useful for vaccines and diagnostics
12/29/1999EP0967223A2 Hepatitis C virus peptide antigens and a method of testing for the hepatitis C virus (HCV)
12/29/1999EP0967220A1 Novel arabinosyladenine derivatives
12/29/1999EP0966535A1 Epitopes of the protein pre-m/m of the dengue virus, synthetic peptides
12/29/1999EP0966523A1 Method for the production of selected lymphocytes
12/29/1999EP0966511A2 Washing disinfectant for hygienic and surgical hand disinfection
12/29/1999EP0966487A1 Polyvalent carbohydrate molecules
12/29/1999EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
12/29/1999EP0966472A1 Cephalosporin derivatives
12/29/1999EP0966465A1 Inhibitors of impdh enzyme
12/29/1999EP0966457A1 Ring opening metathesis of alkenes
12/29/1999EP0966431A1 Salicylic acid-sphingoid base derivatives and uses thereof
12/29/1999EP0966303A2 Polypeptide conjugates for transporting substances across cell membranes
12/29/1999EP0966296A1 Conjugated peptides, immunological reagent containing same and use thereof for treatment of immunological disorders
12/29/1999EP0966245A2 Antimicrobial cosmetic compositions
12/29/1999EP0966196A1 Composition for organ cryopreservation and treatment of viral and bacterial infections
12/29/1999EP0751788B1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
12/29/1999EP0654031B1 Stereoselective synthesis of nucleoside analogues using bicyclic intermediate
12/29/1999EP0635062B1 METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF mRNA
12/29/1999EP0614372B1 Antiviral factor from cd8+ cells
12/29/1999EP0614369B1 Pharmaceutical dipeptide compositions and methods of use thereof
12/29/1999EP0564645B1 Transformant cells for the prophylaxis or treatment of diseases caused by viruses, particularly pathogenic retroviruses
12/29/1999EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999CN1240001A Mutants of streptococcal toxin C and methods of use
12/29/1999CN1239966A Novel erythromycin derivatives, method for preparing them and their use as medicine
12/29/1999CN1239963A Novel cephem derivatives
12/29/1999CN1239941A Aryl or heteroaryl substd. 3, 4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo [1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs.
12/29/1999CN1239895A Radiopharmaceuticals for imaging infection and inflammation
12/29/1999CN1239669A Composition of Radix Sophorae Flavescentis and green tea and its application in treating condyloma
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2336160A1 Use of compounds for treating hiv
12/29/1999CA2335989A1 Stable no-delivering compounds
12/29/1999CA2335956A1 Compounds obtained from salvia species having antiviral activity
12/29/1999CA2335636A1 Sticking plaster for controlled release of natural interferon
12/29/1999CA2335571A1 (heterocyclic) methyl substituted carbapenem antibacterials
12/29/1999CA2335559A1 Arylsulfonanilide phosphates
12/29/1999CA2335538A1 (heterocyclic)methyl substituted carbapenem antibacterials
12/29/1999CA2335510A1 Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
12/29/1999CA2335507A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999CA2335497A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
12/29/1999CA2335288A1 Propenyl cephalosporin derivatives
12/29/1999CA2334645A1 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
12/29/1999CA2331888A1 Novel staphylococcus peptides for bacterial interference
12/29/1999CA2330526A1 Particles of hcv envelope proteins: use for vaccination
12/29/1999CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999CA2330178A1 Synthetic peptide vaccines for foot-and-mouth disease
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/28/1999US6008356 Pharmaceutically available protoberberine salts derivatives, and protoberberine salts derivatives, and protoberberine derivatives and salts thereof
12/28/1999US6008341 A dna molecule; vaccine to prevent staphylococcus infections, promote wound healing, block adhesion of host plasma and matrix proteins to medical devices after implantation, therapy for sepsis and infections of the heart
12/28/1999US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent
12/28/1999US6008225 Derivatives of antibiotic GE2270 factors C2a, D2 and E
12/28/1999US6008201 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
12/28/1999US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999US6008192 Hydrophilic binary systems for the administration of lipophilic compounds
12/28/1999US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/28/1999US6008033 A herpes simplex virus-2 protease or diisopropylphosphate-liganded herpes simplex virus-2 protease in orthorhombic crystalline form; for computer models and screening for enzyme inhibitors as viricides
12/28/1999US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999US6007841 Effective narcotic agonist-antagonist analgesic potentiated by concurrently administered nontoxic n-methyl-d-aspartate receptor antagonist
12/28/1999US6007822 Immunogenic plant extract mixed into animal feed; bactericides, viricides, free radical scavengers, antioxidants
12/28/1999US6007818 Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent
12/28/1999US6007816 Reducing transmigration of lymphocytes through endothelium into lymph node or inflamed synovium by administering monoclonal antibody specifically binding to a hybridized mammalian dna encoded polypeptide
12/28/1999US6007805 Use of interferon subtype alpha-8 (IFN-α8) to treat viral infections of the liver
12/28/1999US6007803 Administering to mammal a cationic polymer to inhibit pathogenic toxins
12/28/1999US6007686 System for elctrolyzing fluids for use as antimicrobial agents
12/28/1999CA2143163C Peptides derived from a retrovirus of the hiv group, and their use
12/28/1999CA2131769C Novel cephalosporin antibiotics and processes for preparation thereof
12/28/1999CA2005990C Antiretroviral aryloxy substituted furan ketones
12/28/1999CA2001715C Carbocyclic nucleosides and nucleotides
12/28/1999CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/28/1999CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999WO1999066065A2 Proteasomal activity
12/23/1999WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
1 ... 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 ... 1798